Total planned funding: $713,038,406
Clear active filters
Zimbabwe
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Zimbabwe | $713,038,406 |
Organizational Types
NGO | $225,946,011 |
Private Contractor | $162,893,813 |
Unknown | $88,129,249 |
University | $84,295,840 |
Own Agency | $79,419,970 |
Implementing Agency | $49,061,524 |
FBO | $21,175,999 |
Other USG Agency | $1,066,000 |
Host Country Government Agency | $1,000,000 |
Multi-lateral Agency | $50,000 |
Program Areas
Treatment | $235,275,804 |
Prevention | $178,232,217 |
Care | $154,681,547 |
Testing | $53,557,042 |
Governance and Systems | $48,488,253 |
Management and Operations | $42,803,543 |
Budget Codes
HTXS: Treatment: Adult Treatment | $152,217,455 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $96,108,717 |
HKID: Care: Orphans and Vulnerable Children | $88,292,908 |
HTXD: Treatment: ARV Drugs | $75,142,331 |
HVCT: Testing: HIV Testing and Counseling | $53,557,042 |
HVOP: Sexual Prevention: Other Sexual Prevention | $43,265,883 |
HVMS: Management and Operations | $42,803,543 |
HBHC: Care: Adult Care and Support | $35,466,108 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $24,515,376 |
OHSS: Health Systems Strengthening | $24,477,975 |
HVTB: Care: TB/HIV | $19,908,957 |
HVSI: Strategic Information | $14,597,715 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $14,342,241 |
PDCS: Care: Pediatric Care and Support | $11,013,574 |
HLAB: Laboratory Infrastructure | $9,412,563 |
PDTX: Treatment: Pediatric Treatment | $7,916,018 |
HMBL: Biomedical Prevention: Blood Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Chemonics International:
$127,923,922
Countries/Regions
University of Washington:
$93,644,664
Countries/Regions
Not Available:
$85,620,672
Countries/Regions
FHI 360:
$53,072,198
Countries/Regions